The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care
Author:
Funder
National Institutes of Health
NIDDK
Baylor
Publisher
Elsevier BV
Reference24 articles.
1. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study;Tapper;BMJ,2018
2. Burden of liver diseases in the world;Asrani;J Hepatol,2019
3. Hepatocellular carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US;Singal;Am J Med,2017
4. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension;De Franchis;J Hepatol,2015
5. Rifaximin treatment in hepatic encephalopathy;Bass;N Engl J Med,2010
Cited by 171 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management;Livers;2025-06-25
2. Telemedicine approaches for patients with cirrhosis, including vulnerable populations: A narrative review;Canadian Liver Journal;2025-05-01
3. Limitations in real-world telemonitoring applicability in gastroenterology and hepatology: a systematic review;Frontline Gastroenterology;2025-04-08
4. Association between self-perceptions of aging, care deferrals, and change in health status among US adults aged ≥ 50 years during the COVID-19 pandemic: A cross-sectional study;Journal of Health Psychology;2025-03-18
5. Post COVID Condition and Long‐Term COVID‐19 Impact on Hepatic Decompensation and Survival in Cirrhosis: A Propensity Matched Observational Study;JGH Open;2025-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3